Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-038538
Filing Date
2022-06-21
Accepted
2022-06-21 19:22:17
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5805
  Complete submission text file 0001209191-22-038538.txt   7266
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARSANIS, INC. 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address
Gerngross Tillman U. (Reporting) CIK: 0001722061 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 221029547